[1] | M. M. H. Abdelbary et al., “The oral-gut axis: Salivary and fecal microbiome dysbiosis in patients with inflammatory bowel disease,” Front Cell Infect Microbiol, vol. 12, p. 1010853, 2022, doi: 10.3389/fcimb.2022.1010853. |
[2] | C. A. Arnold et al., “Sexually transmitted infectious colitis vs inflammatory bowel disease: distinguishing features from a case-controlled study,” Am J Clin Pathol, vol. 144, no. 5, pp. 771–781, Nov. 2015, doi: 10.1309/AJCPOID4JIJ6PISC. |
[3] | Y. S. Choi et al., “Clinical Characteristics and Incidence of Perianal Diseases in Patients With Ulcerative Colitis,” Ann Coloproctol, vol. 34, no. 3, pp. 138–143, Jun. 2018, doi: 10.3393/ac.2017.06.08. |
[4] | M. Doublali et al., “Perianal abscesses due to ingested foreign bodies,” J Emerg Trauma Shock, vol. 3, no. 4, pp. 395–397, Oct. 2010, doi: 10.4103/0974-2700.70769. |
[5] | M. Gajendran et al., “A comprehensive review and update on ulcerative colitis,” Disease-a-Month, vol. 65, no. 12, p. 100851, Dec. 2019, doi: 10.1016/j.disamonth.2019.02.004. |
[6] | S. Hegde et al., “Microbiota dysbiosis and its pathophysiological significance in bowel obstruction,” Sci Rep, vol. 8, no. 1, p. 13044, Sep. 2018, doi: 10.1038/s41598-018-31033-0. |
[7] | T. Innocenti et al., “Pregnancy outcomes in inflammatory bowel disease: Data from a large cohort survey,” J Dig Dis, vol. 23, no. 8–9, pp. 473–481, Aug. 2022, doi: 10.1111/1751-2980.13128. |
[8] | M. Jimenez and N. Mandava, “Anorectal fistula,” 2020, Accessed: May 30, 2024. [Online]. Available: https://europepmc.org/books/nbk560657 |
[9] | M. Katouli, “Population structure of gut Escherichia coli and its role in development of extra-intestinal infections,” Iran J Microbiol, vol. 2, no. 2, pp. 59–72, Jun. 2010. |
[10] | A. Kojima, R. Nomura, S. Naka, R. Okawa, T. Ooshima, and K. Nakano, “Aggravation of inflammatory bowel diseases by oral streptococci,” Oral Dis, vol. 20, no. 4, pp. 359–366, May 2014, doi: 10.1111/odi.12125. |
[11] | P. Lv, P. Liu, X. Zhou, and J. Liu, “A case of reactive arthritis caused by a perianal abscess,” SAGE Open Med Case Rep, vol. 11, p. 2050313X231177764, 2023, doi: 10.1177/2050313X231177764. |
[12] | M. Marzo et al., “Management of perianal fistulas in Crohn’s disease: an up-to-date review,” World J Gastroenterol, vol. 21, no. 5, pp. 1394–1403, Feb. 2015, doi: 10.3748/wjg.v21.i5.1394. |
[13] | L. Y. McGirt and C. R. Martins, “Dermatologic diagnoses in the perianal area,” Clin Colon Rectal Surg, vol. 17, no. 4, pp. 241–245, Nov. 2004, doi: 10.1055/s-2004-836945. |
[14] | M. Meseeha and M. Attia, “Proctitis and Anusitis,” 2017, Accessed: May 30, 2024. [Online]. Available: https://europepmc.org/article/nbk/nbk430892 |
[15] | P. T. Santana, S. L. B. Rosas, B. E. Ribeiro, Y. Marinho, and H. S. P. de Souza, “Dysbiosis in Inflammatory Bowel Disease: Pathogenic Role and Potential Therapeutic Targets,” Int J Mol Sci, vol. 23, no. 7, p. 3464, Mar. 2022, doi: 10.3390/ijms23073464. |
[16] | M. Scharl, G. Rogler, and L. Biedermann, “Fistulizing Crohn’s Disease,” Clin Transl Gastroenterol, vol. 8, no. 7, p. e106, Jul. 2017, doi: 10.1038/ctg.2017.33. |
[17] | Z. Tan et al., “Causal Link between Inflammatory Bowel Disease and Fistula: Evidence from Mendelian Randomization Study,” J Clin Med, vol. 12, no. 7, p. 2482, Mar. 2023, doi: 10.3390/jcm12072482. |
[18] | Z. Tan et al., “Causal Link between Inflammatory Bowel Disease and Fistula: Evidence from Mendelian Randomization Study,” J Clin Med, vol. 12, no. 7, p. 2482, Mar. 2023, doi: 10.3390/jcm12072482. |
[19] | S. H. Waqar, S. A. Shah, I. Rashid, and F. Shahzad, “Comparison of Sitz bath alone versus Sitz bath with Antibiotic therapy in the management of uncomplicated Perianal Abscess,” Annals of PIMS-Shaheed Zulfiqar Ali Bhutto Medical University, vol. 19, no. 4, pp. 477–480, 2023. |
[20] | H. M. Wexler, “Bacteroides: the good, the bad, and the nitty-gritty,” Clin Microbiol Rev, vol. 20, no. 4, pp. 593–621, Oct. 2007, doi: 10.1128/CMR.00008-07. |
[21] | M. H. Whiteford, “Perianal abscess/fistula disease,” Clin Colon Rectal Surg, vol. 20, no. 2, pp. 102–109, May 2007, doi: 10.1055/s-2007-977488. |
[22] | X. Wu, X. Liu, S. Katz, and B. Shen, “Pathogenesis, diagnosis, and management of ulcerative proctitis, chronic radiation proctopathy, and diversion proctitis,” Inflammatory bowel diseases, vol. 21, no. 3, pp. 703–715, 2015. |
[23] | R. Wyllie, J. S. Hyams, and M. Kay, Pediatric gastrointestinal and liver disease E-Book. Elsevier Health Sciences, 2020. Accessed: May 30, 2024. [Online]. Available: https://books.google.fr/books?hl=en&lr=&id=eB__DwAAQBAJ&oi=fnd&pg=PP1&dq=Walls+RM,+et+al., +eds.+%22Disorders+of+the+anorectum%22.+&ots=evSkfE5iDd&sig=KgPijJ9E5FcJkNxJDr2qNTZcS7s. |
[24] | R. J. Xavier and H. J. Thomas, “Gastrointestinal Diseases,” in Hunter’s Tropical Medicine and Emerging Infectious Disease, Elsevier, 2013, pp. 18–27. doi: 10.1016/B978-1-4160-4390-4.00003-5. |
[25] | X.-R. Xu, C.-Q. Liu, B.-S. Feng, and Z.-J. Liu, “Dysregulation of mucosal immune response in pathogenesis of inflammatory bowel disease,” World J Gastroenterol, vol. 20, no. 12, pp. 3255–3264, Mar. 2014, doi: 10.3748/wjg.v20.i12.3255. |